The Brief Brief Science
what we just learned about everything.
Science — briefly, then briefly again · tbb.ceo
listen tothe daily 0:00 –:––
/daily ·17 JUL 2026 ·FRIDAY ·3 MIN READ ·7 STORIES

Friday in Science: Atmospheres, Antimatter, and Ancient Warriors

An exoplanet in the habitable zone turns out to have kept its atmosphere, radium molecules near absolute zero narrow the search for why matter exists, and skeletal evidence overturns what we thought about Egyptian royal women.

01 / The Day

FRIDAY 17 JUL 2026, ranked

07

Rocky Habitable-Zone Planet Has an Atmosphere

LHS 1140b, an Earth-mass rocky world 40 light-years away, is venting helium at a rate low enough to imply the planet is actively replenishing its atmosphere — the first such detection on a rocky world orbiting in a habitable zone. The observation does not confirm life, but it confirms the search is not theoretical.

Why it mattersA rocky planet capable of holding an atmosphere at the right orbital distance is the prerequisite the field has been hunting for; JWST follow-up will look for water and CO2.

Radium Molecules, Cooled to -268°C, May Explain Why Anything Exists

Caltech researchers embedded radium in molecules and chilled them to near absolute zero, exploiting the element's pear-shaped nucleus to amplify sensitivity to matter-antimatter asymmetry by orders of magnitude. The tabletop experiment hunts for particles and forces the standard model does not account for.

Why it mattersThe matter-antimatter imbalance that allowed the universe to contain more than nothing remains unexplained; radium molecules are a new class of precision probe aimed at the cause.

Excitons in Thin Crystals Can Rewrite Magnetic States Using Light

A review in Nature Materials documents that light-generated excitons in layered magnetic semiconductors like chromium triiodide do not passively sit atop the magnetism — they can sense spin order and, under the right conditions, control it. Writing magnetic information with a light pulse removes the fields and currents that generate heat in conventional approaches.

Why it mattersOptical control of magnetic states in atom-thin materials is a pathway to memory devices and quantum transducers that run cool and fast.

Egyptian Royal Women Were Trained in Archery and Combat

Skeletal analysis of six 12th-Dynasty mummies from Dahshur — including daughters of Pharaoh Amenemhat II — found enlarged forearm bones, muscle attachments consistent with regular bow use, and healed traumatic injuries. The daggers and bows buried with them appear to have been working equipment, not symbols.

Why it mattersBioarchaeological data from these six mummies overturns textual assumptions about circumscribed roles for elite women in ancient Egypt.

Common Gut Bacterium Route to Colon Cancer: A Specific Receptor

Researchers traced the mechanism by which a toxin from Bacteroides fragilis binds to claudin-4, a protein on colon cell surfaces, initiating the cascade toward cancer — and a decoy protein blocking that receptor suppressed tumor growth in mice.

Why it mattersIdentifying the specific molecular handshake between a ubiquitous gut bacterium and colon cells creates a targetable step in the second most lethal cancer globally.

Graphene Nanoribbons Survive Gamma Rays and Still Measure Them

Nine-atom-wide graphene nanoribbons exposed to gamma radiation maintained structural integrity while showing measurable, reproducible drops in electrical conductivity — the combination required for a sensor that functions in the environment it is monitoring. The effect arises from Anderson localization triggered by radiation-induced edge changes.

Why it mattersFusion reactors and deep-space missions need sensors that work under conditions that destroy conventional electronics; graphene nanoribbons are a credible candidate.

A Decade-Scale Gap Found Between Huntington Mutation and Brain Collapse

Research confirms the mutant HTT gene slowly accumulates extra CAG repeats over decades before neurons begin to fail rapidly — with DNA repair gene MSH3 controlling the pace of that expansion. The first therapies targeting MSH3 are entering human trials in late 2026.

Why it mattersA therapeutically addressable window spanning decades before irreversible neurological damage reframes a previously inevitable disease.
Be subscriber #012 the weekly ten, every friday by email · no spam · unsubscribe anytime
Past days

The Daily Archive